Epidemiological and economic burden of Clostridium difficile in the United States: Estimates from a modeling approach

Authors

Kamal Desai, Evidera Inc.
Swati B. Gupta, Merck & Co., Inc.
Erik R. Dubberke, Washington University School of Medicine in St. Louis
Vimalanand S. Prabhu, Merck & Co., Inc.
Chantelle Browne, Evidera Inc.
T. Christopher Mast, Merck & Co., Inc.

Journal

BMC Infectious Diseases

Publication Date

2016

Volume

16

Inclusive Pages

303

Document Type

Open Access Publication

DOI

10.1186/s12879-016-1610-3

Rights and Permissions

Desai et al. BMC Infectious Diseases (2016) 16:303 DOI 10.1186/s12879-016-1610-3

Recommended Citation

Desai, Kamal; Gupta, Swati B.; Dubberke, Erik R.; Prabhu, Vimalanand S.; Browne, Chantelle; and Mast, T. Christopher, "Epidemiological and economic burden of Clostridium difficile in the United States: Estimates from a modeling approach." BMC Infectious Diseases. 16, 303. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5015